Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Straumann Holding AG
- Novartis
Comparative performance (base 100)
Each asset is worth 100 at October 13, 2025; a value of 120 means +20% since that date (latest common date: October 9, 2026).
Each performance is calculated in the asset's trading currency, without currency conversion.
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | Straumann Holding AGStock | NovartisStock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | −0.2% | +14.0% |
| Annualized performanceAverage annual return that would produce the same total performance. | −0.2% | +14.1% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 34.4% | 24.8% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −27.6% | −15.0% |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 0.02 | 0.52 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −3.3% | −2.2% |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 17.73B $ | 228.01B CHF |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 37.7 | 22.8 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 6.7 | 4.0 |
| Net marginShare of revenue retained as profit. | 14.0% | 22.5% |
| Return on equityReturn on equity (ROE). | 17.0% | 30.3% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +2.3% | +0.8% |
| Dividend yieldAnnual dividend relative to the share price. | 1.18% | 3.11% |
| Debt / equityFinancial debt relative to shareholders' equity. | 21% | 117% |
Correlations over the period
From −1 to 1: close to 1, the two assets rise and fall together; close to 0, they move independently.
- Straumann Holding AG / Novartis0.16
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.